1. Home
  2. HPS vs CLPT Comparison

HPS vs CLPT Comparison

Compare HPS & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Hancock Preferred Income Fund III Preferred Income Fund III

HPS

John Hancock Preferred Income Fund III Preferred Income Fund III

HOLD

Current Price

$12.18

Market Cap

465.8M

Sector

Finance

ML Signal

HOLD

Logo ClearPoint Neuro Inc.

CLPT

ClearPoint Neuro Inc.

HOLD

Current Price

$15.33

Market Cap

467.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HPS
CLPT
Founded
N/A
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
465.8M
467.9M
IPO Year
2003
2009

Fundamental Metrics

Financial Performance
Metric
HPS
CLPT
Price
$12.18
$15.33
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $20.00
AVG Volume (30 Days)
123.2K
★ 550.5K
Earning Date
01-01-0001
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $36,971,000.00
Revenue This Year
N/A
$45.67
Revenue Next Year
N/A
$19.51
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 17.78
52 Week Low
$12.04
$8.27
52 Week High
$15.68
$30.10

Technical Indicators

Market Signals
Indicator
HPS
CLPT
Relative Strength Index (RSI) 15.78 51.16
Support Level N/A $14.65
Resistance Level $14.66 $15.29
Average True Range (ATR) 0.23 0.69
MACD -0.07 0.15
Stochastic Oscillator 3.76 48.00

Price Performance

Historical Comparison
HPS
CLPT

About HPS John Hancock Preferred Income Fund III Preferred Income Fund III

John Hancock Preferred Income Fund III is a closed-end, diversified management investment company. Its investment objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve the objectives by investing a majority of its assets in preferred stocks and other preferred securities, including convertible preferred securities. The portfolio composition of the company consists of the U.S. preferred securities, foreign preferred securities, common stocks, corporate bonds, and the short-term investments.

About CLPT ClearPoint Neuro Inc.

ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.

Share on Social Networks: